Growth Metrics

BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025)

BioNTech SE (BNTX) posted Other Non-Current Assets of $202.3 million for Q4 2025, down 40.92% on a QoQ basis from $342.4 million in Q3 2025, and down 10.99% year-over-year from $227.3 million in Q4 2024.

BioNTech SE (BNTX) has 7 years of Other Non-Current Assets data on file, last reported at $202.3 million in Q4 2025.

  • In Q4 2025, Other Non-Current Assets fell 10.99% year-over-year to $202.3 million; the TTM figure through Dec 2025 stood at $202.3 million (down 10.99% YoY), while the FY2025 annual figure was $196.4 million, down 13.61% from the prior year.
  • Other Non-Current Assets eased to $202.3 million in Q4 2025, from $342.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $386.9 million in Q2 2024 and bottomed at $49.7 million in Q2 2022.
  • A 5-year average of $226.3 million and a median of $231.2 million in 2023 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 364.92% — and 2025, when it tumbled 37.1%.
  • Year by year, Other Non-Current Assets stood at $129.7 million in 2021, then rose by 26.46% to $164.0 million in 2022, then jumped by 84.24% to $302.2 million in 2023, then dropped by 24.8% to $227.3 million in 2024, then fell by 10.99% to $202.3 million in 2025.
  • The last three Other Non-Current Assets figures came in at $202.3 million (Q4 2025), $342.4 million (Q3 2025), and $243.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 BioNTech SE 27.66 Bn 7.53 Bn 668.28 Mn 202.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 202.31 Mn
Sep 30, 2025 342.42 Mn
Jun 30, 2025 243.37 Mn
Mar 31, 2025 246.46 Mn
Dec 31, 2024 227.29 Mn
Sep 30, 2024 302.89 Mn
Jun 30, 2024 386.93 Mn
Mar 31, 2024 366.10 Mn
Dec 31, 2023 302.23 Mn
Sep 30, 2023 311.55 Mn
Jun 30, 2023 231.18 Mn
Mar 31, 2023 183.86 Mn
Sep 30, 2022 164.05 Mn
Jun 30, 2022 49.72 Mn
Mar 31, 2022 72.84 Mn
Dec 31, 2021 129.73 Mn
Mar 31, 2021 83.95 Mn
Dec 31, 2019 10.04 Mn
Sep 30, 2019 10.40 Mn
Dec 31, 2018 10.46 Mn